CPT1a, the critical and rate limiting enzyme of FAO is also direct target of STAT3 (148) and STAT3 signaling and switching of CD8+ T cell effector metabolism from glycolysis to FAO was associated with decreased effector T cell numbers and function and more aggressive breast tumor development (Figure 2, Table 1). This evidence concerns the gene STAT3 and breast neoplasm.